Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Visceral Pain Pipeline Report, H2 2017 - Therapeutics Review of 10 Companies & Drug Profiles - Research and Markets

Research and Markets
Posted on: 18 Aug 17

The "Visceral Pain - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Pharmaceutical and Healthcare latest pipeline guide Visceral Pain - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Visceral Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Visceral Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Visceral Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, IND/CTA Filed and Preclinical stages are 1, 1 and 11 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 4 molecules, respectively.

Visceral Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Visceral Pain - Overview
  3. Visceral Pain - Therapeutics Development
  4. Pipeline Overview
  5. Pipeline by Companies
  6. Pipeline by Universities/Institutes
  7. Products under Development by Companies
  8. Products under Development by Universities/Institutes
  9. Visceral Pain - Therapeutics Assessment
  10. Assessment by Target
  11. Assessment by Mechanism of Action
  12. Assessment by Route of Administration
  13. Assessment by Molecule Type
  14. Visceral Pain - Companies Involved in Therapeutics Development
  • Addex Therapeutics Ltd
  • Anavex Life Sciences Corp
  • Arena Pharmaceuticals Inc
  • BELLUS Health Inc
  • Cadila Healthcare Ltd
  • Chromocell Corp
  • Eli Lilly and Company
  • Grunenthal GmbH
  • Medestea Research & Production SpA
  • Pfizer Inc

For more information about this report visit https://www.researchandmarkets.com/research/mxz6hk/visceral_pain

View source version on businesswire.com: http://www.businesswire.com/news/home/20170818005225/en/

Business Wire
www.businesswire.com

Last updated on: 18/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.